Grant: Engage Grants Program
Dalhousie University
$24,859.00
Reversal of both peroxisomal and mitochondrial dysfunction with natural products
FY 2015-16
Summary
Mitochondrial dysfunction resulting in the excessive production of injurious reactive oxygen species is
considered to be a central mechanism in cellular senescence. However, mitochondrial anti-oxidants fail to
improve the longevity of animals suggesting that other mechanisms contribute to aging. Plasmalogens are
essential components of cell membranes that comprise a large proportion of the total mitochondrial lipid
content. These ether lipids are produced exclusively by peroxisomes, organelles known to decline with age
resulting in reduced plasmalogen synthesis. Mutations that impair plasmalogen synthesis lead to mitochondrial
dysfunction that causes oxidative stress and promotes cell death. Mitochondrial deficits produced by these
mutations are attenuated by compounds that increase the production of new peroxisomes and mitochondria.
These findings indicate that peroxisomes and mitochondria are functionally inter-connected and suggest that
both organelles should be targeted to reduce oxidative stress and promote cell survival. To test this hypothesis,
I will determine whether the protective effects of dietary flavonoids (epicatechin and quercetin), known to
improve mitochondrial function, are enhanced by the administration of plasmalogen precursors in a mouse
model of oxidative injury characterized by both peroxisomal and mitochondria dysfunction. This will be done
by determining whether oral administration of epicatechin, quercetin and plasmalogen precursors reduce
hearing loss and kidney damage in mice treated with the chemotherapeutic drug cisplatin that is known to
disrupt the function of peroxisomes and mitochondria.
Program
Engage Grants Program
Recipient
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
489096-2015
Name nom
Weaver, Ian
Department département
Psychology and Neuroscience
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
24859
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
1
Nb partie
1
Application title
Reversal of both peroxisomal and mitochondrial dysfunction with natural products
Keyword
NSERC
Application summary
Mitochondrial dysfunction resulting in the excessive production of injurious reactive oxygen species is
considered to be a central mechanism in cellular senescence. However, mitochondrial anti-oxidants fail to
improve the longevity of animals suggesting that other mechanisms contribute to aging. Plasmalogens are
essential components of cell membranes that comprise a large proportion of the total mitochondrial lipid
content. These ether lipids are produced exclusively by peroxisomes, organelles known to decline with age
resulting in reduced plasmalogen synthesis. Mutations that impair plasmalogen synthesis lead to mitochondrial
dysfunction that causes oxidative stress and promotes cell death. Mitochondrial deficits produced by these
mutations are attenuated by compounds that increase the production of new peroxisomes and mitochondria.
These findings indicate that peroxisomes and mitochondria are functionally inter-connected and suggest that
both organelles should be targeted to reduce oxidative stress and promote cell survival. To test this hypothesis,
I will determine whether the protective effects of dietary flavonoids (epicatechin and quercetin), known to
improve mitochondrial function, are enhanced by the administration of plasmalogen precursors in a mouse
model of oxidative injury characterized by both peroxisomal and mitochondria dysfunction. This will be done
by determining whether oral administration of epicatechin, quercetin and plasmalogen precursors reduce
hearing loss and kidney damage in mice treated with the chemotherapeutic drug cisplatin that is known to
disrupt the function of peroxisomes and mitochondria.